120 related articles for article (PubMed ID: 1526652)
1. Biological activity of mutants of human tumour necrosis factor-alpha.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
[TBL] [Abstract][Full Text] [Related]
2. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
[TBL] [Abstract][Full Text] [Related]
4. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
[TBL] [Abstract][Full Text] [Related]
5. Human TNF mutants with selective activity on the p55 receptor.
Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.
Rathjen DA; Ferrante A; Aston R
Immunology; 1993 Oct; 80(2):293-9. PubMed ID: 8262557
[TBL] [Abstract][Full Text] [Related]
7. Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region.
Fonda I; Pernus M; Gaberc-Porekar V; Kenig M; Stalc A; Meager A; Menart V
Eur Cytokine Netw; 2005; 16(1):17-26. PubMed ID: 15809202
[TBL] [Abstract][Full Text] [Related]
8. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells.
Nakamura S; Masegi T; Fukuoka M; Kitai K; Kato A; Ichikawa Y; Watanabe N; Niitsu Y
Agric Biol Chem; 1991 Jan; 55(1):53-7. PubMed ID: 1369315
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of cytotoxic activity of mutant forms of tumor necrosis factor alpha with changes in the level of free sphingosine in murine liver].
Solov'ev AS; Korobko VG; Shingarova LN; Vasil'eva SV; Makhova EV; Alesenko AV
Biokhimiia; 1995 Aug; 60(8):1283-91. PubMed ID: 7578580
[TBL] [Abstract][Full Text] [Related]
10. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.
Petrova EE; Valyakina TI; Simonova MA; Komaleva RL; Khaidukov SV; Makarov EA; Blokhin DY; Ivanov PK; Andronova TM; Nesmeyanov VA
Int Immunopharmacol; 2006 Sep; 6(9):1377-86. PubMed ID: 16846831
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells.
Ikegami H; Arai N; Moriyasu J; Taniguchi M; Tsusaki K; Honji N; Kohno K; Ando S; Kurimoto M
Lymphokine Cytokine Res; 1993 Jun; 12(3):173-80. PubMed ID: 7688581
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
[TBL] [Abstract][Full Text] [Related]
13. The role of iron in the cytotoxicity of tumor necrosis factor.
Warren S; Torti SV; Torti FM
Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
[TBL] [Abstract][Full Text] [Related]
14. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of human tumor necrosis factor-alpha.
Shin HC; Cho KH
Biotechnol Lett; 2005 Jan; 27(2):107-12. PubMed ID: 15703873
[TBL] [Abstract][Full Text] [Related]
16. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y
Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618
[TBL] [Abstract][Full Text] [Related]
17. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro.
Zinetti M; Galli G; Demitri MT; Fantuzzi G; Minto M; Ghezzi P; Alzani R; Cozzi E; Fratelli M
Immunology; 1995 Nov; 86(3):416-21. PubMed ID: 8550079
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
19. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
20. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
